Estrogen Receptor Signaling in Cancer by Simon P. Langdon

Get full text

Inhibitors of the Fanconi anaemia pathway as potential antitumour agents for ovarian cancer by Sarah J Taylor, Mark J Arends, Simon P Langdon

Get full text

Estrogen Signaling and Its Potential as a Target for Therapy in Ovarian Cancer by Simon P. Langdon, C. Simon Herrington, Robert L. Hollis, Charlie Gourley

Get full text

Evaluation of Gene Expression Data From Cybrids and Tumours Highlights Elevated -Driven Proliferation in Triple-Negative Breast Cancer by Akanksha Mishra, Maria Bonello, Adam Byron, Simon P Langdon, Andrew H Sims

Get full text

Human blastomere rotation in early cleavage embryos is not associated with reduced implantation: Evidence from time-lapse videography by Emma P Langdon, Yan-he Liu, Phillip L Matson, Peter J Mark

Get full text

Nuclear factor erythroid 2-related factor 2 modulates HER4 receptor in ovarian cancer cells to influence their sensitivity to tyrosine kinase inhibitors by Ibrahim H. Kankia, Poornima Paramasivan, Matthew Elcombe, Simon P. Langdon, Yusuf Y. Deeni

Get full text

Increased STAT1 signaling in endocrine-resistant breast cancer. by Rui Huang, Dana Faratian, Andrew H Sims, Danielle Wilson, Jeremy S Thomas, David J Harrison, Simon P Langdon

Get full text

Sprouty 2 is an independent prognostic factor in breast cancer and may be useful in stratifying patients for trastuzumab therapy. by Dana Faratian, Andrew H Sims, Peter Mullen, Charlene Kay, Inhwa Um, Simon P Langdon, David J Harrison

Get full text

Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel Biomarkers. by Romina Briffa, Inhwa Um, Dana Faratian, Ying Zhou, Arran K Turnbull, Simon P Langdon, David J Harrison

Get full text

A chironomid-based mean July temperature inference model from the south-east margin of the Tibetan Plateau, China by E. Zhang, J. Chang, Y. Cao, H. Tang, P. Langdon, J. Shulmeister, R. Wang, X. Yang, J. Shen

Get full text

The impact of tumour pH on cancer progression: strategies for clinical intervention by Carol Ward, James Meehan, Mark E Gray, Alan F Murray, David J Argyle, Ian H Kunkler, Simon P Langdon

Get full text

Systems Analysis of Drug-Induced Receptor Tyrosine Kinase Reprogramming Following Targeted Mono- and Combination Anti-Cancer Therapy by Alexey Goltsov, Yusuf Deeni, Hilal S. Khalil, Tero Soininen, Stylianos Kyriakidis, Huizhong Hu, Simon P. Langdon, David J. Harrison, James Bown

Get full text

HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer by Edward J. Jarman, Carol Ward, Arran K. Turnbull, Carlos Martinez-Perez, James Meehan, Chrysi Xintaropoulou, Andrew H. Sims, Simon P. Langdon

Get full text

RFWD3 modulates response to platinum chemotherapy and promotes cancer associated phenotypes in high grade serous ovarian cancer by Sarah J. Taylor, Sarah J. Taylor, Robert L. Hollis, Charlie Gourley, C. Simon Herrington, C. Simon Herrington, Simon P. Langdon, Mark J. Arends

Get full text

Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment by Chrysi Xintaropoulou, Carol Ward, Alan Wise, Suzanna Queckborner, Arran Turnbull, Caroline O. Michie, Alistair R. W. Williams, Tzyvia Rye, Charlie Gourley, Simon P. Langdon

Get full text

Development and characterisation of acquired radioresistant breast cancer cell lines by Mark Gray, Arran K. Turnbull, Carol Ward, James Meehan, Carlos Martínez-Pérez, Maria Bonello, Lisa Y. Pang, Simon P. Langdon, Ian H. Kunkler, Alan Murray, David Argyle

Get full text

Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer by James Meehan, Mark Gray, Mark Gray, Carlos Martínez-Pérez, Carlos Martínez-Pérez, Charlene Kay, Lisa Y. Pang, Jennifer A. Fraser, Amy V. Poole, Ian H. Kunkler, Simon P. Langdon, David Argyle, Arran K. Turnbull, Arran K. Turnbull

Get full text